Latest filing published 04 Sept 2026 for Editas Medicine, Inc., €1,187.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Amy Parison: trading record in brief
This profile gathers the share dealings of Amy Parison in Editas Medicine, Inc. Between 3 June 2025 and 3 September 2026, the trades on record add up to 8 filings.
Sales make up the whole of the open-market record (8 sales, €8,650). 2026 to date brings no purchases and 4 sales.
The latest filing, published on 4 September 2026, reports an open-market sale of €1,187 in Editas Medicine, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Amy Parison
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 453 shares@ US$3.03720.0003% mcap13.7% of flowCommon StockSEC:0002063082-26-000006:0
- 678 shares@ US$2.580.0004% mcap20.3% of flowCommon StockSEC:0002063082-26-000003:0
- 464 shares@ US$2.7010.0003% mcap100.0% of flowCommon StockSEC:0001650664-26-000057:0
- 474 shares@ US$2.0213.8% of flowCommon StockSEC:0001650664-26-000007:0
- 461 shares@ US$2.153116.6% of flowCommon StockSEC:0001650664-25-000161:0
- 458 shares@ US$2.596123.9% of flowCommon StockSEC:0001650664-25-000142:0
- 679 shares@ US$2.5846.1% of flowCommon StockSEC:0001650664-25-000118:0
- 446 shares@ US$1.72438.5% of flowCommon StockSEC:0001650664-25-000093:0
8 of 8 declarations
